CAMBRIDGE, Mass., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today that the company will participate in the Morgan Stanley Global Health Care Conference in New York City. Marc D. Beer, CEO of Aegerion, is scheduled to present on Tuesday, September 11, 2012 at 4:30 p.m. ET.
